Evolution of Cardiovascular Risk Factors in a Worker Cohort: A Cluster Analysis

Sara Castel-Feced1,2,3, Lina Maldonado4, Isabel Aguilar-Palacio1,2,3

  • 1Department of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.

Insights

Identifying cardiovascular risk factor (CVRF) profiles helps prevent cardiovascular disease (CVD). This study found distinct worker groups, with one showing better CVRF control and slower risk score increase over time, enabling personalized prevention strategies.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Data Science in Healthcare

Background:

  • Cardiovascular disease (CVD) prevention relies on identifying individual cardiovascular risk factor (CVRF) profiles.
  • Personalized preventive strategies are crucial for effective CVD risk reduction.
  • Longitudinal tracking of CVRFs and risk scores is essential for understanding disease progression.

Purpose of the Study:

  • To characterize the evolution of CVRFs and the CVD risk score (SCORE) in a cohort of workers over time.
  • To identify distinct patient profiles based on the temporal changes in CVRFs.
  • To inform the development of tailored medical approaches for CVD prevention.

Main Methods:

  • Utilized data from annual medical examinations between 2009 and 2017.
  • Employed descriptive analyses (mean, standard deviation, quartiles, percentages) for quantitative and categorical variables.
  • Applied cluster analysis using the Kml3D package in R software to group individuals based on CVRF evolution.

Main Results:

  • Cluster analysis divided the cohort into two distinct groups (clusters).
  • Cluster 1 consisted of younger workers with favorable CVRF profiles (lower BMI, waist circumference, glucose, SCORE; higher HDL).
  • Cluster 2 exhibited opposite characteristics to Cluster 1.
  • Over time, Cluster 1 demonstrated superior CVRF control improvement and a lesser increase in SCORE compared to Cluster 2.

Conclusions:

  • Distinct CVRF evolution profiles exist within a working population.
  • Individuals in Cluster 1 showed better CVRF management and lower SCORE progression.
  • Identifying these profiles can guide personalized CVD preventive measures and enhance public health strategies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
473
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
5.5K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
287
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
563
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
662
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
565